Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2011 (2011), Article ID 239515, 5 pages
http://dx.doi.org/10.4061/2011/239515
Review Article

In Peritoneal Dialysis, Is There Sufficient Evidence to Make “PD First” Therapy?

1Division of Nephrology, Department of Internal Medicine, University of Missouri, Columbia, Mo 65212, USA
2Division of Nephrology, Harry S Truman Veterans's Hospital, Columbia, Mo 65201, USA

Received 19 January 2011; Revised 6 April 2011; Accepted 20 April 2011

Academic Editor: Hulya Taskapan

Copyright © 2011 Pranav Dalal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. “USRDS data system: USRDS annual data report,” Bethesda MD, 2009.
  2. P. G. Blake and F. O. Finkelstein, “Why is the proportion of patients doing peritoneal dialysis declining in North America?” Peritoneal Dialysis International, vol. 21, no. 2, pp. 107–114, 2001. View at Google Scholar · View at Scopus
  3. R. Mehrotra, D. Kermah, L. Fried et al., “Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes,” Journal of the American Society of Nephrology, vol. 18, no. 10, pp. 2781–2788, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. E. F. Vonesh, J. J. Snyder, R. N. Foley, and A. J. Collins, “The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis,” Kidney International, vol. 66, no. 6, pp. 2389–2401, 2004. View at Google Scholar · View at Scopus
  5. J. G. Heaf, H. Løkkegaard, and M. Madsen, “Initial survival advantage of peritoneal dialysis relative to haemodialysis,” Nephrology Dialysis Transplantation, vol. 17, no. 1, pp. 112–117, 2002. View at Google Scholar · View at Scopus
  6. S. S. Fenton, D. E. Schaubel, M. Desmeules et al., “Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates,” American Journal of Kidney Diseases, vol. 30, no. 3, pp. 334–342, 1997. View at Google Scholar · View at Scopus
  7. B. G. Jaar, J. Coresh, L. C. Plantinga et al., “Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease,” Annals of Internal Medicine, vol. 143, no. 3, pp. 174–183, 2005. View at Google Scholar
  8. R. Mehrotra, Y.W. Chiu, K. Kalantar-Zadeh, J. Bargman, and E. Vonesh, “Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease,” Archives of Internal Medicine, vol. 171, no. 2, pp. 110–118, 2011. View at Publisher · View at Google Scholar · View at PubMed
  9. R. Mehrotra, Y. W. Chiu, K. Kalantar-Zadeh, and E. Vonesh, “The outcomes of continuous ambulatory and automated peritoneal dialysis are similar,” Kidney International, vol. 76, no. 1, pp. 97–107, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. S. P. McDonald, M. R. Marshall, D. W. Johnson, and K. R. Polkinghorne, “Relationship between dialysis modality and mortality,” Journal of the American Society of Nephrology, vol. 20, no. 1, pp. 155–163, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. D. J. Hirsch, K. K. Jindal, D. E. Schaubel, and S. S. Fenton, “Peritoneal dialysis reduces the use of non native fistula access in dialysis programs,” Advances in Peritoneal Dialysis, vol. 15, pp. 121–124, 1999. View at Google Scholar · View at Scopus
  12. C. T. Liao, Y. M. Chen, C. C. Shiao et al., “Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis,” Nephrology Dialysis Transplantation, vol. 24, no. 9, pp. 2909–2914, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. A. Y. Wang and K. N. Lai, “The importance of residual renal function in dialysis patients,” Kidney International, vol. 69, no. 10, pp. 1726–1732, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. L. M. Moist, F. K. Port, S. M. Orzol et al., “Predictors of loss of residual renal function among new dialysis patients,” Journal of the American Society of Nephrology, vol. 11, no. 3, pp. 556–564, 2000. View at Google Scholar · View at Scopus
  15. A. Y. Wang, M. Wang, J. Woo et al., “Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients,” Journal of the American Society of Nephrology, vol. 15, no. 8, pp. 2186–2194, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. P. K. Li, K. M. Chow, T. Y. Wong, C. B. Leung, and C. C. Szeto, “Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis: a randomized, controlled study,” Annals of Internal Medicine, vol. 139, no. 2, pp. 105–112, 2003. View at Google Scholar · View at Scopus
  17. N. Aslam, J. Bernardini, L. Fried, R. Burr, and B. Piraino, “Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients,” Clinical Journal of the American Society of Nephrology, vol. 1, no. 6, pp. 1226–1233, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. N. R. Powe, B. Jaar, S. L. Furth, J. Hermann, and W. Briggs, “Septicemia in dialysis patients: incidence, risk factors, and prognosis,” Kidney International, vol. 55, no. 3, pp. 1081–1090, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. F. H. Bender, J. Bernardini, and B. Piraino, “Prevention of infectious complications in peritoneal dialysis: best demonstrated practices,” Kidney International Supplements, vol. 70, no. 103, pp. S44–S54, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. J. B. Wasserfallen, M. Moinat, G. Halabi et al., “Satisfaction of patients on chronic haemodialysis and peritoneal dialysis,” Swiss Medical Weekly, vol. 136, no. 13-14, pp. 210–217, 2006. View at Google Scholar · View at Scopus
  21. H. R. Rubin, N. E. Fink, L. C. Plantinga, J. H. Sadler, A. S. Kliger, and N. R. Powe, “Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis,” Journal of the American Medical Association, vol. 291, no. 6, pp. 697–703, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. R. Vanholder, P. Heering, A. Van Loo et al., “Reduced incidence of acute renal graft failure in patients treated with peritoneal dialysis compared with hemodialysis,” American Journal of Kidney Diseases, vol. 33, no. 5, pp. 934–940, 1999. View at Google Scholar · View at Scopus
  23. R. Palomar, P. Morales, E. Rodrigo et al., “Venous graft thrombosis in patients on peritoneal dialysis before transplantation,” Transplantation Proceedings, vol. 39, no. 7, pp. 2128–2130, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. Y. Chalem, J. P. Ryckelynck, P. Tuppin, C. Verger, S. Chauvé, and D. Glotz, “Access to, and outcome of, renal transplantation according to treatment modality of end-stage renal disease in France,” Kidney International, vol. 67, no. 6, pp. 2448–2453, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. A. S. Goldfarb-Rumyantzev, J. F. Hurdle, J. D. Scandling, B. C. Baird, and A. K. Cheung, “The role of pretransplantation renal replacement therapy modality in kidney allograft and recipient survival,” American Journal of Kidney Diseases, vol. 46, no. 3, pp. 537–549, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. Y. C. Shih, A. Guo, P. M. Just, and S. Mujais, “Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients,” Kidney International, vol. 68, no. 1, pp. 319–329, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. A. Berger, J. Edelsberg, G. W. Inglese, S. K. Bhattacharyya, and G. Oster, “Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease,” American Journal of Managed Care, vol. 15, no. 8, pp. 509–518, 2009. View at Google Scholar · View at Scopus
  28. “Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group,” Journal of the American Society of Nephrology, vol. 7, no. 2, pp. 198–207, 1996.
  29. R. Paniagua, D. Amato, E. Vonesh et al., “Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial,” Journal of the American Society of Nephrology, vol. 13, no. 5, pp. 1307–1320, 2002. View at Google Scholar · View at Scopus
  30. W. K. Lo, Y. W. Ho, C. S. Li et al., “Effect of Kt/V on survival and clinical outcome in CAPD patients in a randomized prospective study,” Kidney International, vol. 64, no. 2, pp. 649–656, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. P. J. Margetts and D. N. Churchill, “Acquired ultrafiltration dysfunction in peritoneal dialysis patients,” Journal of the American Society of Nephrology, vol. 13, no. 11, pp. 2787–2794, 2002. View at Google Scholar · View at Scopus
  32. M. L. Lambie, B. John, L. Mushahar, C. Huckvale, and S. J. Davies, “The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made,” Kidney International, vol. 78, no. 6, pp. 611–618, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. K. J. Jager, M. P. Merkus, F. W. Dekker et al., “Mortality and technique failure in patients starting chronic peritoneal dialysis: results of the netherlands cooperative study on the adequacy of dialysis,” Kidney International, vol. 55, no. 4, pp. 1476–1485, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. Y. Kawaguchi, T. Hasegawa, M. Nakayama, H. Kubo, and T. Shigematu, “Issues affecting the longevity of the continuous peritoneal dialysis therapy,” Kidney International, vol. 51, no. 62, pp. S105–S107, 1997. View at Google Scholar · View at Scopus
  35. R. Kuriyama, A. Tranaeus, and T. Ikegami, “Icodextrin reduces mortality and the drop-out rate in japanese peritoneal dialysis patients,” Advances in Peritoneal Dialysis, vol. 22, pp. 108–110, 2006. View at Google Scholar · View at Scopus
  36. H. Y. Choi, D. K. Kim, T. H. Lee et al., “The clinical usefulness of peritoneal dialysis fluids with neural pH and low glucose degradation product concentration: an open randomized prospective trial,” Peritoneal Dialysis International, vol. 28, no. 2, pp. 174–182, 2008. View at Google Scholar · View at Scopus
  37. B. Rippe, O. Simonsen, O. Heimbürger et al., “Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products,” Kidney International, vol. 59, no. 1, pp. 348–357, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. J. H. Crabtree and R. J. Burchette, “Effective use of laparoscopy for long-term peritoneal dialysis access,” American Journal of Surgery, vol. 198, no. 1, pp. 135–141, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. T. Golper, “Patient education: can it maximize the success of therapy?” Nephrology Dialysis Transplantation, vol. 16, supplement 7, pp. 20–24, 2001. View at Google Scholar · View at Scopus